Shah NB, Zuckerman AD, Hosteng KR, Fann J, et al. Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease. Dig Dis Sci 2023 Sep 19. doi: 10.1007/s10620-023-08098.
PMID: 37725192